A man with prostate cancer who was receiving androgen blockade had a substantial reduction in the frequency of hot flashes with the use of fezolinetant.
The New England Journal of Medicine: Search Results in Hematology/Oncology
Neurokinin-3 Receptor Antagonism for Refractory Hot Flashes in Men
